Thalidomide-induced orofacial neuropathy
- PMID: 25275775
- PMCID: PMC4442672
- DOI: 10.1097/RHU.0000000000000176
Thalidomide-induced orofacial neuropathy
Conflict of interest statement
Figures
References
-
- Bastuji-Garin S, Ochonisky S, Bouche P, et al. Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients. J Invest Dermatol. 2002;119:1020–1026. - PubMed
-
- Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol. 1979;115:1409–1415. - PubMed
-
- Reed BR, Huff JC, Jones SK, et al. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med. 1985;103:49–51. - PubMed
-
- Callen JP. Drug-induced subacute cutaneous lupus erythematosus - filling the gap in knowledge [published online July 10, 2013] JAMA Dermatol - PubMed
-
- Gronhagen CM, Fored CM, Linder M, et al. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden. Br J Dermatol. 2012;167:296–305. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical